Cardiovascular fixed dose combination pill (acetylsalicylic acid, simvastatin and ramipril)
AssetAlso Cardiovascular fixed dose combination pill
Fixed-dose polypill combining acetylsalicylic acid, simvastatin, and ramipril for cardiovascular risk reduction
- Stage
- Phase 2
- Modality
- Small molecule
- Target
- Lipid and ceramide metabolism
- 1
- Indication
- 916
- Trials
- 1
- Developer
Indications
1Elevated ldl cholesterol
Phase 2, Terminated, NCT01362218, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains7
- Owner and partners1
- Trials916
- Evidence for its targets7
- Competitors8
- Aging relevance2
- Signals12
Every asset’s record: target, stage, trials and the evidence behind it.
Updated 7 Oct 2026, 5 sources